Ethyl 2-carbamoyloxybenzoate

CAS No. 88599-32-0

Ethyl 2-carbamoyloxybenzoate( —— )

Catalog No. M28404 CAS No. 88599-32-0

Ethyl 2-carbamoyloxybenzoate is a compound used as a molecular building block.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 Get Quote
5MG 74 Get Quote
10MG 111 Get Quote
25MG 188 Get Quote
50MG 284 Get Quote
100MG 426 Get Quote
500MG 972 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ethyl 2-carbamoyloxybenzoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethyl 2-carbamoyloxybenzoate is a compound used as a molecular building block.
  • Description
    Ethyl 2-carbamoyloxybenzoate is a compound used as a molecular building block.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    88599-32-0
  • Formula Weight
    209.201
  • Molecular Formula
    C10H11NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(=O)c1ccccc1OC(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liang L, Wang X, Sun Y, Ma P, Li X, Piao H, Jiang Y, Song D. Magnetic solid-phase extraction of triazine herbicides from rice using metal-organic framework MIL-101(Cr) functionalized magnetic particles. Talanta. 2018 Mar 1;179:512-519. doi: 10.1016/j.talanta.2017.11.017. Epub 2017 Nov 28. PubMed PMID: 29310269.
molnova catalog
related products
  • (-)-Benzotetramisole

    (-)-Benzotetramisole makes an efficient and selective catalyst. (-)-Benzotetramisole is a benzannulated derivative of the anthelmintic compound tetraimidazole 3 and is itself an effective catalyst for conversion.

  • Ciamexon

    Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.

  • RBC10

    RBC10 inhibits the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines.